Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Logo for

J. Biol. Chem. 277 (46): 44155-44163

© 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

Control of Receptor-induced Signaling Complex Formation by the Kinetics of Ligand/Receptor Interaction*

Anja Krippner-Heidenreich, Fabian Tübing, Susanne Bryde, Sylvia Willi, Gudrun Zimmermann, and Peter ScheurichDagger

From the Institute of Cell Biology and Immunology, University of Stuttgart, Allmandring 31, 70569 Stuttgart, Germany

Tumor necrosis factor (TNF) exists both as a membrane-integrated type II precursor protein and a soluble cytokine that have different bioactivities on TNFR2 (CD120b) but not on TNFR1 (CD120a). To identify the molecular basis of this disparity, we have investigated receptor chimeras comprising the cytoplasmic part of Fas (CD95) and the extracellular domains of the two TNF receptors. The membrane form of TNF, but not its soluble form, was capable of inducing apoptosis as well as activation of c-Jun N-terminal kinase and NF-kappa B via the TNFR2-derived chimera. In contrast, the TNFR1-Fas chimera displayed strong responsiveness to both TNF forms. This pattern of responsiveness is identical to that of wild type TNF receptors, demonstrating that the underlying mechanisms are independent of the particular type of the intracellular signaling machinery and rather are controlled upstream of the intracellular domain. We further demonstrate that the signaling strength induced by a given ligand/receptor interaction is regulated at the level of adaptor protein recruitment, as shown for FADD, caspase-8, and TRAF2. Since both incidents, strong signaling and robust adapter protein recruitment, are paralleled by a high stability of individual ligand-receptor complexes, we propose that half-lives of individual ligand-receptor complexes control signaling at the level of adaptor protein recruitment.


* This work was supported by Deutsche Forschungsgemeinschaft Grant GR 1307/3-3 and Sonderforschungsbereich 495, project A4.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 49-711-685-6987; Fax: 49-711-685-7484.


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
An anti-TNFR1 scFv-HSA fusion protein as selective antagonist of TNF action.
V. Berger, F. Richter, K. Zettlitz, F. Unverdorben, P. Scheurich, A. Herrmann, K. Pfizenmaier, and R. E. Kontermann (2013)
Protein Eng. Des. Sel. 26, 581-587
   Abstract »    Full Text »    PDF »
The IgM CH2 domain as covalently linked homodimerization module for the generation of fusion proteins with dual specificity.
O. Seifert, A. Plappert, N. Heidel, S. Fellermeier, S. K. E. Messerschmidt, F. Richter, and R. E. Kontermann (2012)
Protein Eng. Des. Sel. 25, 603-612
   Abstract »    Full Text »    PDF »
The Tumor Necrosis Factor Receptor Stalk Regions Define Responsiveness to Soluble versus Membrane-Bound Ligand.
C. Richter, S. Messerschmidt, G. Holeiter, J. Tepperink, S. Osswald, A. Zappe, M. Branschadel, V. Boschert, D. A. Mann, P. Scheurich, et al. (2012)
Mol. Cell. Biol. 32, 2515-2529
   Abstract »    Full Text »    PDF »
Clock Gene Modulation by TNF-{alpha} Depends on Calcium and p38 MAP Kinase Signaling.
S. Petrzilka, C. Taraborrelli, G. Cavadini, A. Fontana, and T. Birchler (2009)
J Biol Rhythms 24, 283-294
   Abstract »    PDF »
Single-Chain TNF, a TNF Derivative with Enhanced Stability and Antitumoral Activity.
A. Krippner-Heidenreich, I. Grunwald, G. Zimmermann, M. Kuhnle, J. Gerspach, T. Sterns, S. D. Shnyder, J. H. Gill, D. N. Mannel, K. Pfizenmaier, et al. (2008)
J. Immunol. 180, 8176-8183
   Abstract »    Full Text »    PDF »
Creation and X-ray Structure Analysis of the Tumor Necrosis Factor Receptor-1-selective Mutant of a Tumor Necrosis Factor-{alpha} Antagonist.
H. Shibata, Y. Yoshioka, A. Ohkawa, K. Minowa, Y. Mukai, Y. Abe, M. Taniai, T. Nomura, H. Kayamuro, H. Nabeshi, et al. (2008)
J. Biol. Chem. 283, 998-1007
   Abstract »    Full Text »    PDF »
Tumor Necrosis Factor (TNF) Receptor Type 2 Is an Important Mediator of TNF alpha Function in the Mouse Ovary.
C. R. Greenfeld, K. F. Roby, M. E. Pepling, J. K. Babus, P. F. Terranova, and J. A. Flaws (2007)
Biol Reprod 76, 224-231
   Abstract »    Full Text »    PDF »
The Met-196 -> Arg Variation of Human Tumor Necrosis Factor Receptor 2 (TNFR2) Affects TNF-{alpha}-induced Apoptosis by Impaired NF-{kappa}B Signaling and Target Gene Expression.
A. Till, P. Rosenstiel, A. Krippner-Heidenreich, S. Mascheretti-Croucher, P. J. P. Croucher, H. Schafer, P. Scheurich, D. Seegert, and S. Schreiber (2005)
J. Biol. Chem. 280, 5994-6004
   Abstract »    Full Text »    PDF »
Bistability Analyses of a Caspase Activation Model for Receptor-induced Apoptosis.
T. Eissing, H. Conzelmann, E. D. Gilles, F. Allgower, E. Bullinger, and P. Scheurich (2004)
J. Biol. Chem. 279, 36892-36897
   Abstract »    Full Text »    PDF »
Targeted Bioactivity of Membrane-Anchored TNF by an Antibody-Derived TNF Fusion Protein.
S. Bauer, N. Adrian, B. Williamson, C. Panousis, N. Fadle, J. Smerd, I. Fettah, A. M. Scott, M. Pfreundschuh, and C. Renner (2004)
J. Immunol. 172, 3930-3939
   Abstract »    Full Text »    PDF »

To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882